Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.

NCT00029822 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00029822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00029822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2001
Completion date
March 31, 2005
Enrollment
1,522 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy, prostatic hyperplasia, urinary retention